½ÃÀ庸°í¼­
»óǰÄÚµå
1618164

ÀÇ·á±â±â ¼³°è ¹× °³¹ß ¼­ºñ½º ±âȸ ¹× ÃËÁø¿äÀÎ, »ê¾÷ µ¿Ç⠺м® ¹× ¿¹Ãø(2024-2032³â)

Medical Device Design and Development Services Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2024 - 2032

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Global Market Insights Inc. | ÆäÀÌÁö Á¤º¸: ¿µ¹® 145 Pages | ¹è¼Û¾È³» : 2-3ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

¼¼°è ÀÇ·á±â±â ¼³°è ¹× °³¹ß ¼­ºñ½º ½ÃÀåÀº 2023³â 104¾ï ´Þ·¯ ±Ô¸ð·Î Æò°¡µÇ¾ú°í, 2024-2032³â°£ ¿¬Æò±Õ 12.1% ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ÀÌ ½ÃÀå¿¡´Â Çõ½ÅÀûÀÎ ÄÁ¼ÁÀ» ½ÃÀå Ãâ½Ã °¡´ÉÇÑ ÀÇ·á±â±â·Î ÀüȯÇÏ´Â µ¥ ÇʼöÀûÀÎ ´Ù¾çÇÑ Àü¹® ¼­ºñ½º°¡ Æ÷ÇԵ˴ϴÙ. Ãʱ⠼³°è ¹× ¿£Áö´Ï¾î¸µºÎÅÍ ÇÁ·ÎÅäŸÀÌÇÎ, ±ÔÁ¦ ´ëÀÀ, °Ë»ç, Á¦Á¶ ½ºÄÉÀϾ÷¿¡ À̸£±â±îÁö Á¦Ç° °³¹ßÀÇ Àüü ¶óÀÌÇÁ»çÀÌŬÀ» ¾Æ¿ì¸£¸ç ÷´Ü ÀÇ·á±â¼úÀÇ Ã¢ÃâÀ» Áö¿øÇÕ´Ï´Ù. ¸¸¼ºÁúȯÀÇ È®»ê, Àα¸ °í·ÉÈ­, ÀÇ·á ±â¼ú ¹ßÀü µîÀÇ ¿äÀÎÀ¸·Î ÀÎÇØ Áø´Ü ¹× ¼ö¼úÀû °³ÀÔ¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϸ鼭 ½ÃÀå ¼ºÀåÀ» °ßÀÎÇϰí ÀÖ½À´Ï´Ù. ½ÉÇ÷°ü Áúȯ, ´ç´¢º´, ¾Ï°ú °°Àº Áúº´ÀÇ È®»êÀ¸·Î ÀÎÇØ ½Å·ÚÇÒ ¼ö ÀÖ´Â Áø´Ü µµ±¸¿Í ¼ö¼ú Àåºñ¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù.

¼­ºñ½ºº°·Î ½ÃÀåÀ» ºÐ·ùÇÏ¸é ¼³°è ¹× ¿£Áö´Ï¾î¸µ, °¡°ø, Æ÷Àå, ¼ºÇüÀ¸·Î ³ª´µ¸ç, 2023³â¿¡´Â ¼³°è ¹× ¿£Áö´Ï¾î¸µÀÌ ¸ÅÃâÀÇ 37.4%·Î °¡Àå Å« ºñÁßÀ» Â÷ÁöÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ÀÌ ºÎ¹®Àº °³³ä ¼³°è ¹× ÇÁ·ÎÅäŸÀÌÇΰú °°Àº Áß¿äÇÑ ´Ü°è¸¦ Æ÷ÇÔÇϸç, ¾ö°ÝÇÑ ±ÔÁ¦ ±âÁØÀ» ÃæÁ·Çϱâ À§ÇØ Àü¹®ÀûÀÎ ±â¼ú Àü¹® Áö½ÄÀÌ ÇÊ¿äÇϱ⠶§¹®¿¡ Çõ½Å¿¡ ÀÖ¾î °è¼ÓÇØ¼­ ÇʼöÀûÀÔ´Ï´Ù. ¼³°è ¹× ¿£Áö´Ï¾î¸µ¿¡ ´ëÇÑ ÁýÁßÀº °íǰÁúÀÇ ÄÄÇöóÀ̾𽺸¦ ÁؼöÇÏ´Â ÀÇ·á±â±â °³¹ß¿¡ ´ëÇÑ ¾÷°èÀÇ ³ë·ÂÀ» ¹Ý¿µÇÕ´Ï´Ù.

ÀÌ ½ÃÀåÀº ¶ÇÇÑ ¾à¹° Àü´Þ ½Ã½ºÅÛ, Áø´Ü ±â±â, ¼øÈ¯±â ±â±â, Á¤Çü¿Ü°ú ±â±â, È£Èí±â ±â±â µî ´Ù¾çÇÑ Á¦Ç°À» Æ÷°ýÇÏ´Â ±â±â À¯Çüº°·Î ºÐ·ùµË´Ï´Ù. ¾à¹° Àü´Þ ÀåÄ¡ ºÎ¹®Àº 2023³â 13.3%ÀÇ Á¡À¯À²·Î ¼±µÎ¸¦ ´Þ¸®°í ÀÖ½À´Ï´Ù. »ý¹°ÇÐÀû Á¦Á¦ ¹× ¹ÙÀÌ¿À½Ã¹Ð·¯¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡ÇÔ¿¡ µû¶ó º¹ÀâÇÑ Ä¡·áÁ¦¸¦ Åõ¿©ÇÒ ¼ö Àִ ÷´Ü Àü´Þ ½Ã½ºÅÛ¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡ÇÔ¿¡ µû¶ó ¾à¹° Àü´ÞÀº ½ÃÀåÀÇ Áß¿äÇÑ ±¸¼º ¿ä¼Ò·Î ºÎ»óÇϰí ÀÖ½À´Ï´Ù. ¹Ì±¹ÀÇ ÀÇ·á±â±â ¼³°è ¹× °³¹ß ¼­ºñ½º ½ÃÀåÀº 2023³â 28¾ï ´Þ·¯ÀÇ ¸ÅÃâÀ» ±â·ÏÇÒ °ÍÀ¸·Î ¿¹»óµÇ¸ç, 2032³â¿¡´Â 79¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î Àü¸ÁµË´Ï´Ù. ¹Ì±¹Àº ÀΰøÁö´É(AI), ·Îº¿°øÇÐ, 3D ÇÁ¸°ÆÃ, ¹ÙÀÌ¿ÀÅ×Å©³î·¯ÁöÀÇ ¹ßÀüÀ» Ȱ¿ëÇÏ¿© º¸´Ù È¿À²ÀûÀ̰í Á¤È®ÇÏ¸ç °³ÀÎÈ­µÈ ÀÇ·á ¼Ö·ç¼ÇÀ» °³¹ßÇϱâ À§ÇØ ±â¼ú Çõ½ÅÀ» ¼±µµÇϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ °­·ÂÇÑ ÀÔÁö´Â ¸·´ëÇÑ ±Ô¸ðÀÇ º¥Ã³ ijÇÇÅ», Á¤ºÎ º¸Á¶±Ý, ±â°ü ÅõÀÚÀÚµéÀÌ ½ºÅ¸Æ®¾÷°ú ±âÁ¸ ±â¾÷ ¸ðµÎ ½Å±â¼úÀÇ »ó¿ëÈ­¸¦ Áö¿øÇϰí ÀÖ¾î ´õ¿í °­È­µÇ°í ÀÖ½À´Ï´Ù.

½ÃÀå ¹üÀ§
½ÃÀÛ ¿¬µµ 2023³â
¿¹Ãø ¿¬µµ 2024-2032³â
½ÃÀÛ °¡°Ý 104¾ï ´Þ·¯
¿¹ÃøÄ¡ 288¾ï ´Þ·¯
CAGR 12.1%

¸ñÂ÷

Á¦1Àå Á¶»ç ¹æ¹ý°ú Á¶»ç ¹üÀ§

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå »ê¾÷ ÀλçÀÌÆ®

  • »ýÅÂ°è ºÐ¼®
  • »ê¾÷¿¡ ´ëÇÑ ¿µÇâ¿äÀÎ
    • ¼ºÀå ÃËÁø¿äÀÎ
      • ÀÇ·á±â±â ±â¼ú ±Þ¼ÓÇÑ Áøº¸
      • ÀÇ·á Áø´Ü°ú ¿Ü°úÀû °³ÀÔ¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡
      • ÀÇ·á±â±â ¼³°è¡¤°³¹ßÀ» ¿ÜÁÖÇϱâ À§ÇÑ ÅõÀÚ Áõ°¡
      • ½º¸¶Æ® µð¹ÙÀ̽º¿Í ÄÚ³×Å©Åݵå¸ÞµðÄ«¸£Ä« äÅà Ȯ´ë
    • »ê¾÷ÀÇ ÀáÀçÀû ¸®½ºÅ©¿Í °úÁ¦
      • ¾ö°ÝÇÑ ±ÔÁ¦¿Í ½ÂÀÎ ÇÁ·Î¼¼½º
      • ½ÃÀå Âü¿©¿Í »óȯ È®º¸¿¡ °üÇÑ ¿ì·Á
  • ¼ºÀå °¡´É¼º ºÐ¼®
  • ±ÔÁ¦ »óȲ
  • ±â¼úÀû Àü¸Á
    • ÄÚ¾î ±â¼ú
    • ÀÎÁ¢ ±â¼ú
  • ÇâÈÄ ½ÃÀå µ¿Çâ
  • Porter's Five Forces ºÐ¼®
  • PESTEL ºÐ¼®

Á¦4Àå °æÀï ±¸µµ

  • ¼­·Ð
  • ±â¾÷ Á¡À¯À² ºÐ¼®
  • ±â¾÷ ¸ÅÆ®¸¯½º ºÐ¼®
  • ÁÖ¿ä ½ÃÀå ÁøÃâ±â¾÷ °æÀï ºÐ¼®
  • °æÀï Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º
  • Àü·« ´ë½Ãº¸µå

Á¦5Àå ½ÃÀå ÃßÁ¤¡¤¿¹Ãø : ¼­ºñ½ºº°, 2021-2032³â

  • ÁÖ¿ä µ¿Çâ
  • ¼³°è¡¤¿£Áö´Ï¾î¸µ
  • ±â°è °¡°ø
  • Æ÷Àå
  • ¼ºÇü

Á¦6Àå ½ÃÀå ÃßÁ¤¡¤¿¹Ãø : ÀÇ·á±â±âº°, 2021-2032³â

  • ÁÖ¿ä µ¿Çâ
  • ¾à¹°Àü´Þ ±â±â
    • ÀÚµ¿ ÁÖ»ç±â
    • ÁÖÀÔ ÆßÇÁ
    • ÇÁ¸®ÇÊµå ½Ã¸°Áö
    • ÈíÀÔ±â
    • ³×ºæ¶óÀÌÀú
    • ºñ°­ ½ºÇÁ·¹ÀÌ
    • Àڱó» ÇÇÀÓ ±â±¸(IUD)
    • °æÇÇÆÐÄ¡
  • ½ÉÇ÷°üµð¹ÙÀ̽º
    • º¸Á¶ Àΰø ½ÉÀå
    • ÀüÀΰø ½ÉÀå
    • ÆäÀ̽º¸ÞÀÌÄ¿
    • »ðÀÔÇü Á¦¼¼µ¿±â(ICD)
    • ½ÉÀå ·çÇÁ ·¹ÄÚ´õ
    • ȦÅÍ ¸ð´ÏÅÍ
    • À̺¥Æ® ¸ð´ÏÅÍ
    • ECMO ½Ã½ºÅÛ
    • ¼Ò¸ðǰ
  • POC Áø´Ü Àåºñ
    • Ç÷´ç ¸ð´ÏÅÍ
    • Ç÷¾× ºÐ¼® Àåºñ
    • Ç÷¾Ð°è
    • ÀӽŠ°Ë»ç ŰƮ
    • °¨¿°Áõ °Ë»ç
    • HbA1c °Ë»ç ŰƮ
    • ÀÀ°í °Ë»ç ŰƮ
    • ½ÉÀå ¸¶Ä¿ °Ë»ç
    • °©»ó¼± ÀÚ±Ø È£¸£¸ó °Ë»ç
    • ±âŸ POC Áø´Ü ±â±â
  • Á¤Çü¿Ü°ú ±â±â
    • ÀÇÁö Àåºñ
    • Á¤Çü¿Ü°ú¿ë ³»ºñ°ÔÀÌ¼Ç ½Ã½ºÅÛ
    • ±âŸ Á¤Çü¿Ü°ú ±â±â
  • Ä¡°ú¿ë ±â±â
  • ¿Ü°ú¿ë ±â±â
    • ¼ö¼ú¿ë ·Îº¿
    • ±âŸ ¿Ü°ú¿ë ±â±â
  • ¿µ»ó Áø´Ü ±â±â
    • X¼±
    • MRI ½ºÄ³³Ê
    • ÃÊÀ½ÆÄ
    • CT½ºÄ³³Ê
    • ÇÙ¿µ»ó ½ºÄ³³Ê
  • ¼ö¸é¡¤È£Èí Àåºñ
    • ±âµµ¾ç¾Ð(PAP) Àåºñ
    • ÀΰøÈ£Èí±â
    • »ê¼Ò¹ß»ý±â
    • ±âŸ ¼ö¸é¡¤È£Èí °ü·Ã ±â±â
  • ¾È°ú ±â±â
    • ¾ÈÀú Ä«¸Þ¶ó
    • ½½¸´ ·¥ÇÁ
    • ±¤°£¼· ´ÜÃþ°è
    • °¢¸· Æ®Æ÷±×¶óÇǽýºÅÛ
    • ±âŸ ¾È°ú ±â±â
  • ³»½Ã°æ
  • ´ç´¢º´ Ä¡·á
  • Àΰø¿Í¿ì
  • ½Å°æ ÀÚ±Ø Àåºñ
    • ô¼ö ÀÚ±Ø Àåºñ
    • ³ú½ÉºÎ ÀÚ±Ø Àåºñ
    • ±âŸ ½Å°æ ÀÚ±Ø Àåºñ
  • ±âŸ ÀÇ·á±â±â

Á¦7Àå ½ÃÀå ÃßÁ¤¡¤¿¹Ãø : ¿ëµµº°, 2021-2032³â

  • ÁÖ¿ä µ¿Çâ
  • Ä¡·á
  • Áø´Ü

Á¦8Àå ½ÃÀå ÃßÁ¤¡¤¿¹Ãø : ÃÖÁ¾ ¿ëµµº°, 2021-2032³â

  • ÁÖ¿ä µ¿Çâ
  • ÀÇ·á±â±â ±â¾÷
  • ¹ÙÀÌ¿ÀÅ×Å©³î·¯Áö ±â¾÷

Á¦9Àå ½ÃÀå ÃßÁ¤¡¤¿¹Ãø : Áö¿ªº°, 2021-2032³â

  • ÁÖ¿ä µ¿Çâ
  • ºÏ¹Ì
    • ¹Ì±¹
    • ij³ª´Ù
  • À¯·´
    • µ¶ÀÏ
    • ¿µ±¹
    • ÇÁ¶û½º
    • ½ºÆäÀÎ
    • ÀÌÅ»¸®¾Æ
    • ³×´ú¶õµå
  • ¾Æ½Ã¾ÆÅÂÆò¾ç
    • Áß±¹
    • ÀϺ»
    • Àεµ
    • È£ÁÖ
    • Çѱ¹
  • ¶óƾ¾Æ¸Þ¸®Ä«
    • ºê¶óÁú
    • ¸ß½ÃÄÚ
    • ¾Æ¸£ÇîÆ¼³ª
  • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
    • ³²¾ÆÇÁ¸®Ä«°øÈ­±¹
    • »ç¿ìµð¾Æ¶óºñ¾Æ
    • ¾Æ¶ø¿¡¹Ì¸®Æ®(UAE)

Á¦10Àå ±â¾÷ °³¿ä

  • Celestica
  • Cambridge Design Partnership
  • Creation Technologies
  • Cirtec Medical
  • Donatelle
  • Flex
  • Integer Holdings Corporation
  • Jabil
  • Nordson Corporation
  • Planet Innovation
  • Plexus Corporation
  • Quest Global
  • Sanmina Corporation
  • StarFish Product Engineering
  • Veranex
LSH 25.01.09

The Global Medical Device Design and Development Services Market, valued at USD 10.4 billion in 2023, is projected to grow at a 12.1% CAGR from 2024 to 2032. This market covers a range of specialized services essential for transforming innovative concepts into market-ready medical devices. From initial design and engineering to prototyping, regulatory compliance, testing, and manufacturing scale-up, these services encompass the complete product development lifecycle, supporting the creation of advanced medical technologies. Rising demand for diagnostics and surgical interventions drives market growth, fueled by factors like the increasing prevalence of chronic illnesses, an aging population, and advances in medical technology. The spread of conditions such as cardiovascular disease, diabetes, and cancer has amplified the need for reliable diagnostic tools and surgical equipment.

Segmented by services, the market includes design and engineering, machining, packaging, and molding. In 2023, design and engineering held the largest share, contributing 37.4% of revenue. This segment remains vital to innovation, encompassing key stages like conceptualization and prototyping, requiring specialized technical expertise to meet strict regulatory standards. The focus on design and engineering reflects the industry's commitment to developing high-quality, compliant medical devices.

The market is also categorized by device type, covering a wide range of products, including drug delivery systems, diagnostic devices, cardiovascular devices, orthopedic tools, and respiratory equipment, among others. The drug delivery devices segment led with a 13.3% share in 2023. Increasing demand for biologics and biosimilars has driven the need for sophisticated delivery systems that can administer complex therapeutics, making drug delivery a critical component of the market. The U.S. market for medical device design and development services contributed USD 2.8 billion in 2023 and is expected to reach USD 7.9 billion by 2032. The U.S. leads in technological innovation, leveraging advancements in artificial intelligence (AI), robotics, 3D printing, and biotechnology to develop more efficient, precise, and personalized healthcare solutions. This strong position is further bolstered by substantial venture capital, government grants, and institutional funding, which support both startups and established firms in the commercialization of new technologies.

Market Scope
Start Year2023
Forecast Year2024-2032
Start Value$10.4 Billion
Forecast Value$28.8 Billion
CAGR12.1%

Table of Contents

Chapter 1 Methodology & Scope

  • 1.1 Market scope & definition
  • 1.2 Research design
    • 1.2.1 Research approach
    • 1.2.2 Data collection methods
  • 1.3 Base estimates & calculations
    • 1.3.1 Base year calculation
    • 1.3.2 Key trends for market estimation
  • 1.4 Forecast model
  • 1.5 Primary research and validation
    • 1.5.1 Primary sources
    • 1.5.2 Data mining sources

Chapter 2 Executive Summary

  • 2.1 Industry 360° synopsis

Chapter 3 Industry Insights

  • 3.1 Industry ecosystem analysis
  • 3.2 Industry impact forces
    • 3.2.1 Growth drivers
      • 3.2.1.1 Rapid advancements in medical device technologies
      • 3.2.1.2 Increasing demand for medical diagnosis and surgical interventions
      • 3.2.1.3 Increasing investments to outsource medical device designing and development
      • 3.2.1.4 Growing adoption of smart devices and connected medical car
    • 3.2.2 Industry pitfalls & challenges
      • 3.2.2.1 Stringent regulations and approval process
      • 3.2.2.2 Concerns related to securing market access and reimbursement
  • 3.3 Growth potential analysis
  • 3.4 Regulatory landscape
  • 3.5 Technological landscape
    • 3.5.1 Core technologies
    • 3.5.2 Adjacent technologies
  • 3.6 Future market trends
  • 3.7 Porter's analysis
  • 3.8 PESTEL analysis

Chapter 4 Competitive Landscape, 2023

  • 4.1 Introduction
  • 4.2 Company market share analysis
  • 4.3 Company matrix analysis
  • 4.4 Competitive analysis of major market players
  • 4.5 Competitive positioning matrix
  • 4.6 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Services, 2021 - 2032 ($ Mn)

  • 5.1 Key trends
  • 5.2 Designing & engineering
  • 5.3 Machining
  • 5.4 Packaging
  • 5.5 Moulding

Chapter 6 Market Estimates and Forecast, By Medical Devices, 2021 - 2032 ($ Mn)

  • 6.1 Key trends
  • 6.2 Drug delivery devices
    • 6.2.1 Autoinjectors
    • 6.2.2 Infusion pumps
    • 6.2.3 Prefilled syringes
    • 6.2.4 Inhalers
    • 6.2.5 Nebulizers
    • 6.2.6 Nasal spray
    • 6.2.7 Intrauterine devices (IUDs)
    • 6.2.8 Transdermal patches
  • 6.3 Cardiovascular devices
    • 6.3.1 Ventricular assist devices
    • 6.3.2 Total artificial hearts
    • 6.3.3 Pacemakers
    • 6.3.4 Implantable cardioverter defibrillators (ICDs)
    • 6.3.5 Cardiac loop recorders
    • 6.3.6 Holter monitors
    • 6.3.7 Event monitors
    • 6.3.8 ECMO systems
    • 6.3.9 Consumables
  • 6.4 POC diagnostic equipment
    • 6.4.1 Blood glucose monitor
    • 6.4.2 Blood analyzer
    • 6.4.3 Blood pressure monitor
    • 6.4.4 Pregnancy test kit
    • 6.4.5 Infectious diseases testing
    • 6.4.6 HbA1c testing
    • 6.4.7 Coagulation testing kit
    • 6.4.8 Cardiac markers test
    • 6.4.9 Thyroid stimulating hormone test
    • 6.4.10 Other POC diagnostic equipment
  • 6.5 Orthopedic devices
    • 6.5.1 Prosthetics
    • 6.5.2 Orthopedic navigation systems
    • 6.5.3 Other orthopedic devices
  • 6.6 Dental devices
  • 6.7 Surgical devices
    • 6.7.1 Surgical robots
    • 6.7.2 Other surgical devices
  • 6.8 Imaging devices
    • 6.8.1 X-ray
    • 6.8.2 MRI scanners
    • 6.8.3 Ultrasound
    • 6.8.4 CT scanners
    • 6.8.5 Nuclear imaging scanners
  • 6.9 Sleep & respiratory devices
    • 6.9.1 Positive airway pressure (PAP) devices
    • 6.9.2 Ventilators
    • 6.9.3 Oxygen concentrators
    • 6.9.4 Other sleep and respiratory devices
  • 6.10 Ophthalmology devices
    • 6.10.1 Fundus cameras
    • 6.10.2 Slit lamps
    • 6.10.3 Optical coherence tomography
    • 6.10.4 Corneal topography systems
    • 6.10.5 Other ophthalmology devices
  • 6.11 Endoscopy
  • 6.12 Diabetes care
  • 6.13 Cochlear implants
  • 6.14 Neurostimulators
    • 6.14.1 Spinal cord stimulators
    • 6.14.2 Deep brain stimulators
    • 6.14.3 Other neurostimulators
  • 6.15 Other medical devices

Chapter 7 Market Estimates and Forecast, By Application, 2021 - 2032 ($ Mn)

  • 7.1 Key trends
  • 7.2 Treatment
  • 7.3 Diagnostics

Chapter 8 Market Estimates and Forecast, By End Use, 2021 - 2032 ($ Mn)

  • 8.1 Key trends
  • 8.2 Medical device companies
  • 8.3 Biotechnology companies

Chapter 9 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Mn)

  • 9.1 Key trends
  • 9.2 North America
    • 9.2.1 U.S.
    • 9.2.2 Canada
  • 9.3 Europe
    • 9.3.1 Germany
    • 9.3.2 UK
    • 9.3.3 France
    • 9.3.4 Spain
    • 9.3.5 Italy
    • 9.3.6 Netherlands
  • 9.4 Asia Pacific
    • 9.4.1 China
    • 9.4.2 Japan
    • 9.4.3 India
    • 9.4.4 Australia
    • 9.4.5 South Korea
  • 9.5 Latin America
    • 9.5.1 Brazil
    • 9.5.2 Mexico
    • 9.5.3 Argentina
  • 9.6 Middle East and Africa
    • 9.6.1 South Africa
    • 9.6.2 Saudi Arabia
    • 9.6.3 UAE

Chapter 10 Company Profiles

  • 10.1 Celestica
  • 10.2 Cambridge Design Partnership
  • 10.3 Creation Technologies
  • 10.4 Cirtec Medical
  • 10.5 Donatelle
  • 10.6 Flex
  • 10.7 Integer Holdings Corporation
  • 10.8 Jabil
  • 10.9 Nordson Corporation
  • 10.10 Planet Innovation
  • 10.11 Plexus Corporation
  • 10.12 Quest Global
  • 10.13 Sanmina Corporation
  • 10.14 StarFish Product Engineering
  • 10.15 Veranex
»ùÇà ¿äû ¸ñ·Ï
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
¸ñ·Ï º¸±â
Àüü»èÁ¦